About The Study: The results of this study of 91,460 mother-offspring pairs found no association between in utero corticosteroid and β2-adrenergic agonist exposure and offspring neurodevelopmental outcomes, regardless of the timing of exposure. Despite the limitations and low power of the study, the findings suggest that corticosteroids and β2-adrenergic agonists are safe for pregnant individuals with asthma and the neurodevelopment of their offspring.
Authors: Abir Nagata, Ph.D., of Osaka University in Osaka, Japan, and Toshio Masumoto, Ph.D., of Tottori University in Tottori, Japan, are the corresponding authors.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi: 10.1001/jamanetworkopen.2023.39347)
